Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	antigen binding	IGHV3-53 IGHV3-48 IGHV3-21 LPA CD209 IGHV3-66	4.23e-05	190	67	6	GO:0003823
GeneOntologyMolecularFunction	helicase activity	ZCWPW2 DHX40 SMARCA2 SMARCA4 HELQ	1.89e-04	158	67	5	GO:0004386
GeneOntologyMolecularFunction	ATP-dependent activity	ABCA1 ZCWPW2 DHX40 NAIP SMARCA2 SMARCA4 HELQ BCS1L DNAH7	2.02e-04	614	67	9	GO:0140657
GeneOntologyCellularComponent	cell surface	SLC6A1 MRC1 PDCD1 TAS2R16 ABCA1 SULF1 MRC2 LPA ADGRV1 IL2RG CD209 ADGRG6	1.64e-04	1111	66	12	GO:0009986
GeneOntologyCellularComponent	dense core granule membrane	CADPS VPS13C	4.35e-04	10	66	2	GO:0032127
GeneOntologyCellularComponent	bBAF complex	SMARCA2 SMARCA4	4.35e-04	10	66	2	GO:0140092
GeneOntologyCellularComponent	dense core granule	CADPS VPS13C PLCB2	7.39e-04	56	66	3	GO:0031045
GeneOntologyCellularComponent	npBAF complex	SMARCA2 SMARCA4	8.72e-04	14	66	2	GO:0071564
GeneOntologyCellularComponent	GBAF complex	SMARCA2 SMARCA4	8.72e-04	14	66	2	GO:0140288
GeneOntologyCellularComponent	nBAF complex	SMARCA2 SMARCA4	1.14e-03	16	66	2	GO:0071565
Domain	G_PROTEIN_RECEP_F2_1	CALCR ADGRV1 ADGRL3 ADGRG6	9.20e-06	40	62	4	PS00649
Domain	GPCR_2_extracellular_dom	CALCR ADGRV1 ADGRL3 ADGRG6	9.20e-06	40	62	4	IPR001879
Domain	G_PROTEIN_RECEP_F2_3	CALCR ADGRV1 ADGRL3 ADGRG6	9.20e-06	40	62	4	PS50227
Domain	SnAC	SMARCA2 SMARCA4	1.08e-05	2	62	2	SM01314
Domain	Gln-Leu-Gln_QLQ	SMARCA2 SMARCA4	1.08e-05	2	62	2	IPR014978
Domain	SnAC	SMARCA2 SMARCA4	1.08e-05	2	62	2	IPR029295
Domain	SnAC	SMARCA2 SMARCA4	1.08e-05	2	62	2	PF14619
Domain	QLQ	SMARCA2 SMARCA4	1.08e-05	2	62	2	SM00951
Domain	QLQ	SMARCA2 SMARCA4	1.08e-05	2	62	2	PS51666
Domain	QLQ	SMARCA2 SMARCA4	1.08e-05	2	62	2	PF08880
Domain	G_PROTEIN_RECEP_F2_2	CALCR ADGRV1 ADGRL3 ADGRG6	2.26e-05	50	62	4	PS00650
Domain	7tm_2	CALCR ADGRV1 ADGRL3 ADGRG6	2.26e-05	50	62	4	PF00002
Domain	GPCR_2_secretin-like	CALCR ADGRV1 ADGRL3 ADGRG6	4.67e-05	60	62	4	IPR000832
Domain	GPCR_2-like	CALCR ADGRV1 ADGRL3 ADGRG6	4.67e-05	60	62	4	IPR017981
Domain	G_PROTEIN_RECEP_F2_4	CALCR ADGRV1 ADGRL3 ADGRG6	4.99e-05	61	62	4	PS50261
Domain	HSA	SMARCA2 SMARCA4	6.48e-05	4	62	2	SM00573
Domain	HSA	SMARCA2 SMARCA4	6.48e-05	4	62	2	PS51204
Domain	HSA_dom	SMARCA2 SMARCA4	6.48e-05	4	62	2	IPR014012
Domain	HSA	SMARCA2 SMARCA4	6.48e-05	4	62	2	PF07529
Domain	-	CHST5 ABCA1 IFT22 DHX40 NAIP SMARCA2 SMARCA4 HELQ BCS1L DNAH7	1.59e-04	746	62	10	3.40.50.300
Domain	BRK	SMARCA2 SMARCA4	1.61e-04	6	62	2	SM00592
Domain	BRK_domain	SMARCA2 SMARCA4	1.61e-04	6	62	2	IPR006576
Domain	BRK	SMARCA2 SMARCA4	1.61e-04	6	62	2	PF07533
Domain	Kringle-like	MRC1 MRC2 LPA	1.61e-04	32	62	3	IPR013806
Domain	GPS	ADGRV1 ADGRL3 ADGRG6	1.94e-04	34	62	3	SM00303
Domain	GPCR_2_secretin-like_CS	CALCR ADGRL3 ADGRG6	1.94e-04	34	62	3	IPR017983
Domain	GPS	ADGRV1 ADGRL3 ADGRG6	2.11e-04	35	62	3	PF01825
Domain	GPS	ADGRV1 ADGRL3 ADGRG6	2.30e-04	36	62	3	PS50221
Domain	GPS	ADGRV1 ADGRL3 ADGRG6	2.50e-04	37	62	3	IPR000203
Domain	C-type_lectin_CS	MRC1 MRC2 CD209	3.91e-04	43	62	3	IPR018378
Domain	Helicase_C	DHX40 SMARCA2 SMARCA4 HELQ	4.40e-04	107	62	4	PF00271
Domain	HELICc	DHX40 SMARCA2 SMARCA4 HELQ	4.40e-04	107	62	4	SM00490
Domain	P-loop_NTPase	CHST5 ABCA1 IFT22 DHX40 NAIP SMARCA2 SMARCA4 HELQ BCS1L DNAH7	4.44e-04	848	62	10	IPR027417
Domain	Helicase_C	DHX40 SMARCA2 SMARCA4 HELQ	4.56e-04	108	62	4	IPR001650
Domain	HELICASE_CTER	DHX40 SMARCA2 SMARCA4 HELQ	4.72e-04	109	62	4	PS51194
Domain	HELICASE_ATP_BIND_1	DHX40 SMARCA2 SMARCA4 HELQ	4.72e-04	109	62	4	PS51192
Domain	DEXDc	DHX40 SMARCA2 SMARCA4 HELQ	4.72e-04	109	62	4	SM00487
Domain	Helicase_ATP-bd	DHX40 SMARCA2 SMARCA4 HELQ	4.89e-04	110	62	4	IPR014001
Domain	-	MRC1 MRC2	8.26e-04	13	62	2	2.10.10.10
Domain	FN_type2_col-bd	MRC1 MRC2	9.62e-04	14	62	2	IPR000562
Domain	FN2_2	MRC1 MRC2	9.62e-04	14	62	2	PS51092
Domain	fn2	MRC1 MRC2	9.62e-04	14	62	2	PF00040
Domain	FN2_1	MRC1 MRC2	9.62e-04	14	62	2	PS00023
Domain	FN2	MRC1 MRC2	9.62e-04	14	62	2	SM00059
Domain	AAA+_ATPase	ABCA1 NAIP BCS1L DNAH7	1.34e-03	144	62	4	IPR003593
Domain	AAA	ABCA1 NAIP BCS1L DNAH7	1.34e-03	144	62	4	SM00382
Domain	C_TYPE_LECTIN_1	MRC1 MRC2 CD209	2.39e-03	80	62	3	PS00615
Domain	Lectin_C	MRC1 MRC2 CD209	2.74e-03	84	62	3	PF00059
Domain	CLECT	MRC1 MRC2 CD209	2.74e-03	84	62	3	SM00034
Domain	C_TYPE_LECTIN_2	MRC1 MRC2 CD209	2.84e-03	85	62	3	PS50041
Domain	C-type_lectin-like	MRC1 MRC2 CD209	2.93e-03	86	62	3	IPR001304
Domain	Ricin_B_lectin	MRC1 MRC2	3.10e-03	25	62	2	PF00652
Domain	HormR	CALCR ADGRL3	3.10e-03	25	62	2	SM00008
Domain	Bromodomain_CS	SMARCA2 SMARCA4	3.35e-03	26	62	2	IPR018359
Domain	RICIN	MRC1 MRC2	3.88e-03	28	62	2	SM00458
Domain	HRM	CALCR ADGRL3	3.88e-03	28	62	2	PF02793
Domain	RICIN_B_LECTIN	MRC1 MRC2	3.88e-03	28	62	2	PS50231
Domain	-	MRC1 MRC2 CD209	4.11e-03	97	62	3	3.10.100.10
Domain	C-type_lectin-like/link	MRC1 MRC2 CD209	4.36e-03	99	62	3	IPR016186
Domain	Ricin_B_lectin	MRC1 MRC2	4.44e-03	30	62	2	IPR000772
Domain	SNF2_N	SMARCA2 SMARCA4	5.04e-03	32	62	2	IPR000330
Domain	SNF2_N	SMARCA2 SMARCA4	5.04e-03	32	62	2	PF00176
Domain	CTDL_fold	MRC1 MRC2 CD209	5.41e-03	107	62	3	IPR016187
Domain	BROMODOMAIN_1	SMARCA2 SMARCA4	6.70e-03	37	62	2	PS00633
Domain	Bromodomain	SMARCA2 SMARCA4	7.06e-03	38	62	2	PF00439
Domain	SET	SETDB2 PRDM14	8.18e-03	41	62	2	PF00856
Pathway	REACTOME_CD22_MEDIATED_BCR_REGULATION	IGHV3-53 IGHV3-48 IGHV3-21 IGHV3-66	8.55e-06	35	53	4	MM17219
Pathway	REACTOME_CLASSICAL_ANTIBODY_MEDIATED_COMPLEMENT_ACTIVATION	IGHV3-53 IGHV3-48 IGHV3-21 IGHV3-66	1.33e-05	39	53	4	MM17212
Pathway	REACTOME_ROLE_OF_LAT2_NTAL_LAB_ON_CALCIUM_MOBILIZATION	IGHV3-53 IGHV3-48 IGHV3-21 IGHV3-66	2.37e-05	45	53	4	MM14912
Pathway	REACTOME_FCGR_ACTIVATION	IGHV3-53 IGHV3-48 IGHV3-21 IGHV3-66	3.07e-05	48	53	4	MM17214
Pathway	REACTOME_ANTIGEN_ACTIVATES_B_CELL_RECEPTOR_BCR_LEADING_TO_GENERATION_OF_SECOND_MESSENGERS	IGHV3-53 IGHV3-48 IGHV3-21 IGHV3-66	4.55e-05	53	53	4	MM15716
Pathway	REACTOME_INITIAL_TRIGGERING_OF_COMPLEMENT	IGHV3-53 IGHV3-48 IGHV3-21 IGHV3-66	4.90e-05	54	53	4	MM14655
Pathway	REACTOME_FCERI_MEDIATED_NF_KB_ACTIVATION	IGHV3-53 IGHV3-48 IGHV3-21 PSMA1 IGHV3-66	4.93e-05	107	53	5	MM14915
Pathway	REACTOME_ROLE_OF_PHOSPHOLIPIDS_IN_PHAGOCYTOSIS	IGHV3-53 IGHV3-48 IGHV3-21 IGHV3-66	5.66e-05	56	53	4	MM14815
Pathway	REACTOME_FCERI_MEDIATED_CA_2_MOBILIZATION	IGHV3-53 IGHV3-48 IGHV3-21 IGHV3-66	6.50e-05	58	53	4	MM14914
Pathway	REACTOME_FCERI_MEDIATED_MAPK_ACTIVATION	IGHV3-53 IGHV3-48 IGHV3-21 IGHV3-66	7.43e-05	60	53	4	MM14913
Pathway	REACTOME_BINDING_AND_UPTAKE_OF_LIGANDS_BY_SCAVENGER_RECEPTORS	IGHV3-53 IGHV3-48 IGHV3-21 IGHV3-66	7.43e-05	60	53	4	MM14872
Pathway	REACTOME_SIGNALING_BY_THE_B_CELL_RECEPTOR_BCR	IGHV3-53 IGHV3-48 IGHV3-21 PSMA1 IGHV3-66	1.29e-04	131	53	5	MM15717
Pathway	REACTOME_EGR2_AND_SOX10_MEDIATED_INITIATION_OF_SCHWANN_CELL_MYELINATION	SMARCA4 ADGRV1 ADGRG6	1.71e-04	29	53	3	M29808
Pathway	REACTOME_FC_EPSILON_RECEPTOR_FCERI_SIGNALING	IGHV3-53 IGHV3-48 IGHV3-21 PSMA1 IGHV3-66	2.43e-04	150	53	5	MM14889
Pathway	REACTOME_COMPLEMENT_CASCADE	IGHV3-53 IGHV3-48 IGHV3-21 IGHV3-66	2.75e-04	84	53	4	MM14653
Pathway	REACTOME_ADAPTIVE_IMMUNE_SYSTEM	IGHV3-53 IGHV3-48 MRC1 PDCD1 IGHV3-21 MRC2 PSMA1 LTN1 CD209 IGHV3-66	2.97e-04	719	53	10	MM14540
Pathway	REACTOME_CROSS_PRESENTATION_OF_SOLUBLE_EXOGENOUS_ANTIGENS_ENDOSOMES	MRC1 MRC2 PSMA1	7.70e-04	48	53	3	MM14528
Pathway	REACTOME_CROSS_PRESENTATION_OF_SOLUBLE_EXOGENOUS_ANTIGENS_ENDOSOMES	MRC1 MRC2 PSMA1	8.68e-04	50	53	3	M510
Pathway	REACTOME_FCGAMMA_RECEPTOR_FCGR_DEPENDENT_PHAGOCYTOSIS	IGHV3-53 IGHV3-48 IGHV3-21 IGHV3-66	8.75e-04	114	53	4	MM14814
Pubmed	1.3 A X-ray structure of an antibody Fv fragment used for induced membrane-protein crystallization.	IGHV3-53 IGHV3-48 IGHV3-21 IGHV3-66	1.69e-08	15	67	4	12657787
Pubmed	Early onset of somatic mutation in immunoglobulin VH genes during the primary immune response.	IGHV3-53 IGHV3-48 IGHV3-21 IGHV3-66	8.96e-08	22	67	4	2499654
Pubmed	Activation of ATP-binding cassette transporter A1 transcription by chromatin remodeling complex.	ABCA1 SMARCA2 SMARCA4	1.36e-07	6	67	3	15774904
Pubmed	CCL2/MCP-1 signaling drives extracellular matrix turnover by diverse macrophage subsets.	MRC1 MRC2 LPA	1.36e-07	6	67	3	33543002
Pubmed	HIV-1 envelope triggers polyclonal Ig class switch recombination through a CD40-independent mechanism involving BAFF and C-type lectin receptors.	MRC1 MRC2 CD209	2.38e-07	7	67	3	16547227
Pubmed	The hbrm and BRG-1 proteins, components of the human SNF/SWI complex, are phosphorylated and excluded from the condensed chromosomes during mitosis.	SMARCA2 SMARCA4	3.66e-06	2	67	2	8670841
Pubmed	Lung cancer with loss of BRG1/BRM, shows epithelial mesenchymal transition phenotype and distinct histologic and genetic features.	SMARCA2 SMARCA4	3.66e-06	2	67	2	23163725
Pubmed	Oligomerization of the macrophage mannose receptor enhances gp120-mediated binding of HIV-1.	MRC1 MRC2	3.66e-06	2	67	2	19224860
Pubmed	Combined gene dosage requirement for SWI/SNF catalytic subunits during early mammalian development.	SMARCA2 SMARCA4	3.66e-06	2	67	2	23076393
Pubmed	Differential preimplantation regulation of two mouse homologues of the yeast SWI2 protein.	SMARCA2 SMARCA4	3.66e-06	2	67	2	9603422
Pubmed	The SWI/SNF chromatin remodeling protein Brg1 is required for vertebrate neurogenesis and mediates transactivation of Ngn and NeuroD.	SMARCA2 SMARCA4	3.66e-06	2	67	2	15576411
Pubmed	Mannose receptor regulation of macrophage cell migration.	MRC1 MRC2	3.66e-06	2	67	2	17596337
Pubmed	SWI/SNF gene variants and glioma risk and outcome.	SMARCA2 SMARCA4	3.66e-06	2	67	2	23276717
Pubmed	Differential Expression of SWI/SNF Chromatin Remodeler Subunits Brahma and Brahma-Related Gene During Drug-Induced Liver Injury and Regeneration in Mouse Model.	SMARCA2 SMARCA4	3.66e-06	2	67	2	27097303
Pubmed	Chromatin remodeling factors and BRM/BRG1 expression as prognostic indicators in non-small cell lung cancer.	SMARCA2 SMARCA4	3.66e-06	2	67	2	15240517
Pubmed	Concomitant loss of SMARCA2 and SMARCA4 expression in small cell carcinoma of the ovary, hypercalcemic type.	SMARCA2 SMARCA4	3.66e-06	2	67	2	26564006
Pubmed	SMARCA4/SMARCA2-deficient Carcinoma of the Esophagus and Gastroesophageal Junction.	SMARCA2 SMARCA4	3.66e-06	2	67	2	33027072
Pubmed	HIV-1 Tat represses transcription from the mannose receptor promoter.	MRC1 MRC2	3.66e-06	2	67	2	11120831
Pubmed	SMARCA4 and SMARCA2 deficiency in non-small cell lung cancer: immunohistochemical survey of 316 consecutive specimens.	SMARCA2 SMARCA4	3.66e-06	2	67	2	28038711
Pubmed	A synthetic lethality-based strategy to treat cancers harboring a genetic deficiency in the chromatin remodeling factor BRG1.	SMARCA2 SMARCA4	3.66e-06	2	67	2	23872584
Pubmed	Proinflammatory stimuli engage Brahma related gene 1 and Brahma in endothelial injury.	SMARCA2 SMARCA4	3.66e-06	2	67	2	23963727
Pubmed	Association of human mannose receptor in sexual transmission of human immunodeficiency virus in serodiscordant couples.	MRC1 MRC2	3.66e-06	2	67	2	23148569
Pubmed	SW13 cells can transition between two distinct subtypes by switching expression of BRG1 and Brm genes at the post-transcriptional level.	SMARCA2 SMARCA4	3.66e-06	2	67	2	12493776
Pubmed	Heterozygous Mutations in SMARCA2 Reprogram the Enhancer Landscape by Global Retargeting of SMARCA4.	SMARCA2 SMARCA4	3.66e-06	2	67	2	31375262
Pubmed	Alterations of the SWI/SNF chromatin remodelling subunit-BRG1 and BRM in hepatocellular carcinoma.	SMARCA2 SMARCA4	3.66e-06	2	67	2	23088494
Pubmed	Aberrant expression of SWI/SNF catalytic subunits BRG1/BRM is associated with tumor development and increased invasiveness in prostate cancers.	SMARCA2 SMARCA4	3.66e-06	2	67	2	17075831
Pubmed	SWI/SNF chromatin remodeling enzyme ATPases promote cell proliferation in normal mammary epithelial cells.	SMARCA2 SMARCA4	3.66e-06	2	67	2	20333683
Pubmed	The mannose receptor on murine liver sinusoidal endothelial cells is the main denatured collagen clearance receptor.	MRC1 MRC2	3.66e-06	2	67	2	17518370
Pubmed	SWI/SNF Complex-deficient Undifferentiated Carcinoma of the Gastrointestinal Tract: Clinicopathologic Study of 30 Cases With an Emphasis on Variable Morphology, Immune Features, and the Prognostic Significance of Different SMARCA4 and SMARCA2 Subunit Deficiencies.	SMARCA2 SMARCA4	3.66e-06	2	67	2	34812766
Pubmed	Loss of SWI/SNF Chromatin Remodeling Alters NRF2 Signaling in Non-Small Cell Lung Carcinoma.	SMARCA2 SMARCA4	3.66e-06	2	67	2	32855269
Pubmed	Targeting of BRM Sensitizes BRG1-Mutant Lung Cancer Cell Lines to Radiotherapy.	SMARCA2 SMARCA4	3.66e-06	2	67	2	30478150
Pubmed	CD4-independent infection of astrocytes by human immunodeficiency virus type 1: requirement for the human mannose receptor.	MRC1 MRC2	3.66e-06	2	67	2	15047828
Pubmed	Downregulation of SWI/SNF chromatin remodeling factor subunits modulates cisplatin cytotoxicity.	SMARCA2 SMARCA4	3.66e-06	2	67	2	22721696
Pubmed	Chromatin remodeling complexes interact dynamically with a glucocorticoid receptor-regulated promoter.	SMARCA2 SMARCA4	3.66e-06	2	67	2	18508913
Pubmed	Compensation of BRG-1 function by Brm: insight into the role of the core SWI-SNF subunits in retinoblastoma tumor suppressor signaling.	SMARCA2 SMARCA4	3.66e-06	2	67	2	11719516
Pubmed	The SWI/SNF ATPases Are Required for Triple Negative Breast Cancer Cell Proliferation.	SMARCA2 SMARCA4	3.66e-06	2	67	2	25808524
Pubmed	Effect of 1,25-dihydroxyvitamin D3 on the expression of mannose receptor, DC-SIGN and autophagy genes in pulmonary tuberculosis.	MRC1 CD209	3.66e-06	2	67	2	27449998
Pubmed	Trypanosoma musculi Infection in Mice Critically Relies on Mannose Receptor-Mediated Arginase Induction by a TbKHC1 Kinesin H Chain Homolog.	MRC1 CD209	3.66e-06	2	67	2	28739879
Pubmed	Antagonistic roles for BRM and BRG1 SWI/SNF complexes in differentiation.	SMARCA2 SMARCA4	3.66e-06	2	67	2	19144648
Pubmed	DNA binding drives the association of BRG1/hBRM bromodomains with nucleosomes.	SMARCA2 SMARCA4	3.66e-06	2	67	2	28706277
Pubmed	[Expression of BRG1 and BRM proteins in prostatic cancer].	SMARCA2 SMARCA4	3.66e-06	2	67	2	21092585
Pubmed	High expression of SMARCA4 or SMARCA2 is frequently associated with an opposite prognosis in cancer.	SMARCA2 SMARCA4	3.66e-06	2	67	2	29391527
Pubmed	Expression of SMARCA2 and SMARCA4 in gastric adenocarcinoma and construction of a nomogram prognostic model.	SMARCA2 SMARCA4	3.66e-06	2	67	2	37634210
Pubmed	SWI/SNF Complex-deficient Undifferentiated/Rhabdoid Carcinomas of the Gastrointestinal Tract: A Series of 13 Cases Highlighting Mutually Exclusive Loss of SMARCA4 and SMARCA2 and Frequent Co-inactivation of SMARCB1 and SMARCA2.	SMARCA2 SMARCA4	3.66e-06	2	67	2	26551623
Pubmed	Noninfectious entry of HIV-1 into peripheral and brain macrophages mediated by the mannose receptor.	MRC1 MRC2	3.66e-06	2	67	2	17360361
Pubmed	SWI/SNF deficiency results in aberrant chromatin organization, mitotic failure, and diminished proliferative capacity.	SMARCA2 SMARCA4	3.66e-06	2	67	2	19458193
Pubmed	Two human homologues of Saccharomyces cerevisiae SWI2/SNF2 and Drosophila brahma are transcriptional coactivators cooperating with the estrogen receptor and the retinoic acid receptor.	SMARCA2 SMARCA4	3.66e-06	2	67	2	8208605
Pubmed	The Bromodomains of the mammalian SWI/SNF (mSWI/SNF) ATPases Brahma (BRM) and Brahma Related Gene 1 (BRG1) promote chromatin interaction and are critical for skeletal muscle differentiation.	SMARCA2 SMARCA4	3.66e-06	2	67	2	34289068
Pubmed	SMARCA4/2 loss inhibits chemotherapy-induced apoptosis by restricting IP3R3-mediated Ca2+ flux to mitochondria.	SMARCA2 SMARCA4	3.66e-06	2	67	2	34518526
Pubmed	SMARCA family of genes.	SMARCA2 SMARCA4	3.66e-06	2	67	2	32312722
Pubmed	Dual loss of the SWI/SNF complex ATPases SMARCA4/BRG1 and SMARCA2/BRM is highly sensitive and specific for small cell carcinoma of the ovary, hypercalcaemic type.	SMARCA2 SMARCA4	3.66e-06	2	67	2	26356327
Pubmed	Loss of BRG1/BRM in human lung cancer cell lines and primary lung cancers: correlation with poor prognosis.	SMARCA2 SMARCA4	3.66e-06	2	67	2	12566296
Pubmed	A Brg1 null mutation in the mouse reveals functional differences among mammalian SWI/SNF complexes.	SMARCA2 SMARCA4	3.66e-06	2	67	2	11163203
Pubmed	Transcriptional specificity of human SWI/SNF BRG1 and BRM chromatin remodeling complexes.	SMARCA2 SMARCA4	3.66e-06	2	67	2	12620226
Pubmed	SMARCA2-deficiency confers sensitivity to targeted inhibition of SMARCA4 in esophageal squamous cell carcinoma cell lines.	SMARCA2 SMARCA4	3.66e-06	2	67	2	31406271
Pubmed	BRG1 and BRM SWI/SNF ATPases redundantly maintain cardiomyocyte homeostasis by regulating cardiomyocyte mitophagy and mitochondrial dynamics in vivo.	SMARCA2 SMARCA4	3.66e-06	2	67	2	27039070
Pubmed	Partial Inactivation of the Chromatin Remodelers SMARCA2 and SMARCA4 in Virus-Infected Cells by Caspase-Mediated Cleavage.	SMARCA2 SMARCA4	3.66e-06	2	67	2	29848589
Pubmed	Co-regulation of transcription by BRG1 and BRM, two mutually exclusive SWI/SNF ATPase subunits.	SMARCA2 SMARCA4	3.66e-06	2	67	2	29273066
Pubmed	HIV-1 interaction with human mannose receptor (hMR) induces production of matrix metalloproteinase 2 (MMP-2) through hMR-mediated intracellular signaling in astrocytes.	MRC1 MRC2	1.10e-05	3	67	2	15955449
Pubmed	Selective Killing of SMARCA2- and SMARCA4-deficient Small Cell Carcinoma of the Ovary, Hypercalcemic Type Cells by Inhibition of EZH2: In Vitro and In Vivo Preclinical Models.	SMARCA2 SMARCA4	1.10e-05	3	67	2	28292935
Pubmed	Clinicopathological and prognostic significance of SWI/SNF complex subunits in undifferentiated gastric carcinoma.	SMARCA2 SMARCA4	1.10e-05	3	67	2	36464671
Pubmed	DNA damage sensitivity of SWI/SNF-deficient cells depends on TFIIH subunit p62/GTF2H1.	SMARCA2 SMARCA4	1.10e-05	3	67	2	30287812
Pubmed	PD-1 signaling negatively regulates the common cytokine receptor γ chain via MARCH5-mediated ubiquitination and degradation to suppress anti-tumor immunity.	PDCD1 IL2RG	1.10e-05	3	67	2	37932447
Pubmed	Immune regulation by fibroblasts in tissue injury depends on uPARAP-mediated uptake of collectins.	MRC1 MRC2	1.10e-05	3	67	2	30366943
Pubmed	Lipoprotein (a) upregulates ABCA1 in liver cells via scavenger receptor-B1 through its oxidized phospholipids.	ABCA1 LPA	1.10e-05	3	67	2	25852127
Pubmed	Distribution of murine mannose receptor expression from early embryogenesis through to adulthood.	MRC1 MRC2	1.10e-05	3	67	2	9560474
Pubmed	The activity of p53 is differentially regulated by Brm- and Brg1-containing SWI/SNF chromatin remodeling complexes.	SMARCA2 SMARCA4	1.10e-05	3	67	2	17938176
Pubmed	Functional redundancy of SWI/SNF catalytic subunits in maintaining vascular endothelial cells in the adult heart.	SMARCA2 SMARCA4	1.10e-05	3	67	2	22740088
Pubmed	BRCA1 interacts with dominant negative SWI/SNF enzymes without affecting homologous recombination or radiation-induced gene activation of p21 or Mdm2.	SMARCA2 SMARCA4	1.10e-05	3	67	2	15034933
Pubmed	TopBP1 recruits Brg1/Brm to repress E2F1-induced apoptosis, a novel pRb-independent and E2F1-specific control for cell survival.	SMARCA2 SMARCA4	1.10e-05	3	67	2	15075294
Pubmed	Comparison of macrophage phenotype between decidua basalis and decidua parietalis by flow cytometry.	MRC1 CD209	1.10e-05	3	67	2	18353434
Pubmed	A putative nuclear receptor coactivator (TMF/ARA160) associates with hbrm/hSNF2 alpha and BRG-1/hSNF2 beta and localizes in the Golgi apparatus.	SMARCA2 SMARCA4	1.10e-05	3	67	2	12044884
Pubmed	SWI/SNF complexes containing Brahma or Brahma-related gene 1 play distinct roles in smooth muscle development.	SMARCA2 SMARCA4	1.10e-05	3	67	2	21518954
Pubmed	Higher-order immunoglobulin repertoire restrictions in CLL: the illustrative case of stereotyped subsets 2 and 169.	IGHV3-48 IGHV3-21	1.10e-05	3	67	2	33036024
Pubmed	HIV gp120 binds to mannose receptor on vaginal epithelial cells and induces production of matrix metalloproteinases.	MRC1 MRC2	1.10e-05	3	67	2	22132194
Pubmed	Heterogeneous SWI/SNF chromatin remodeling complexes promote expression of microphthalmia-associated transcription factor target genes in melanoma.	SMARCA2 SMARCA4	1.10e-05	3	67	2	19784067
Pubmed	Characterization of mammary tumors from Brg1 heterozygous mice.	SMARCA2 SMARCA4	1.10e-05	3	67	2	17637742
Pubmed	BRG1 co-localizes with DNA replication factors and is required for efficient replication fork progression.	SMARCA2 SMARCA4	1.10e-05	3	67	2	20571081
Pubmed	Conserved SNH domain of the proto-oncoprotein SYT interacts with components of the human chromatin remodelling complexes, while the QPGY repeat domain forms homo-oligomers.	SMARCA2 SMARCA4	1.10e-05	3	67	2	14603256
Pubmed	SWI/SNF chromatin remodeling subunit Smarca4/BRG1 is essential for female fertility†.	SMARCA2 SMARCA4	1.10e-05	3	67	2	36440965
Pubmed	The receptors and coding logic for bitter taste.	TAS2R16 PLCB2	1.10e-05	3	67	2	15759003
Pubmed	Ligand-dependent interaction between the estrogen receptor and the human homologues of SWI2/SNF2.	SMARCA2 SMARCA4	1.10e-05	3	67	2	9099865
Pubmed	IMGT/GENE-DB: a comprehensive database for human and mouse immunoglobulin and T cell receptor genes.	IGHV3-53 IGHV3-48 IGHV3-21 IGHV3-66	1.53e-05	77	67	4	15608191
Pubmed	Dual role of NRSF/REST in activation and repression of the glucocorticoid response.	SMARCA2 SMARCA4	2.19e-05	4	67	2	17984088
Pubmed	Nivolumab and Urelumab Enhance Antitumor Activity of Human T Lymphocytes Engrafted in Rag2-/-IL2Rγnull Immunodeficient Mice.	PDCD1 IL2RG	2.19e-05	4	67	2	26113085
Pubmed	Loss of the SWI/SNF-ATPase subunit members SMARCF1 (ARID1A), SMARCA2 (BRM), SMARCA4 (BRG1) and SMARCB1 (INI1) in oesophageal adenocarcinoma.	SMARCA2 SMARCA4	2.19e-05	4	67	2	31906887
Pubmed	Functional specificities of Brm and Brg-1 Swi/Snf ATPases in the feedback regulation of hepatic bile acid biosynthesis.	SMARCA2 SMARCA4	2.19e-05	4	67	2	19805516
Pubmed	M2-like macrophages are responsible for collagen degradation through a mannose receptor-mediated pathway.	MRC1 MRC2	2.19e-05	4	67	2	24019537
Pubmed	SWI/SNF chromatin-remodeling enzymes Brahma-related gene 1 (BRG1) and Brahma (BRM) are dispensable in multiple models of postnatal angiogenesis but are required for vascular integrity in infant mice.	SMARCA2 SMARCA4	2.19e-05	4	67	2	25904594
Pubmed	BRM (SNF2alpha) expression is concomitant to the onset of vasculogenesis in early mouse postimplantation development.	SMARCA2 SMARCA4	2.19e-05	4	67	2	11231080
Pubmed	Oral mucosal expression of HIV-1 receptors, co-receptors, and alpha-defensins: tableau of resistance or susceptibility to HIV infection?	MRC1 CD209	2.19e-05	4	67	2	16672549
Pubmed	BRG1/BRM and prohibitin are required for growth suppression by estrogen antagonists.	SMARCA2 SMARCA4	2.19e-05	4	67	2	15141164
Pubmed	BRG1 and BRM chromatin-remodeling complexes regulate the hypoxia response by acting as coactivators for a subset of hypoxia-inducible transcription factor target genes.	SMARCA2 SMARCA4	2.19e-05	4	67	2	23897427
Pubmed	Neuregulin-1 modulates the differentiation of neural stem cells in vitro through an interaction with the Swi/Snf complex.	SMARCA2 SMARCA4	2.19e-05	4	67	2	19781646
Pubmed	Brahma safeguards canalization of cardiac mesoderm differentiation.	SMARCA2 SMARCA4	2.19e-05	4	67	2	35082446
Pubmed	PD-1-dependent restoration of self-tolerance in the NOD mouse model of diabetes after transient anti-TCRβ mAb therapy.	PDCD1 IL2RG	2.19e-05	4	67	2	25794782
Pubmed	BRG1 and BRM function antagonistically with c-MYC in adult cardiomyocytes to regulate conduction and contractility.	SMARCA2 SMARCA4	2.19e-05	4	67	2	28232072
Pubmed	The clinicopathological significance of SWI/SNF alterations in gastric cancer is associated with the molecular subtypes.	SMARCA2 SMARCA4	2.19e-05	4	67	2	33481850
Pubmed	Mitotic inactivation of a human SWI/SNF chromatin remodeling complex.	SMARCA2 SMARCA4	2.19e-05	4	67	2	9744861
Pubmed	Residual complexes containing SMARCA2 (BRM) underlie the oncogenic drive of SMARCA4 (BRG1) mutation.	SMARCA2 SMARCA4	2.19e-05	4	67	2	24421395
Cytoband	Ensembl 112 genes in cytogenetic band chr8q13	SULF1 MCMDC2 PRDM14	1.94e-04	76	67	3	chr8q13
Cytoband	14q32.33	IGHV3-53 IGHV3-48 IGHV3-21 IGHV3-66	3.55e-04	228	67	4	14q32.33
Cytoband	8q13.1	SULF1 MCMDC2	4.33e-04	21	67	2	8q13.1
GeneFamily	C-type lectin domain family	MRC1 MRC2 CD209	2.96e-04	47	50	3	494
GeneFamily	ADAM metallopeptidase domain containing\|CD molecules	TLR10 MRC1 PDCD1 MRC2 IL2RG CD209	7.29e-04	394	50	6	471
GeneFamily	Immunoglobulin heavy locus at 14q32.33	IGHV3-53 IGHV3-48 IGHV3-21 IGHV3-66	1.76e-03	187	50	4	349
GeneFamily	C2-set domain containing\|Immunoglobulin like domain containing\|Scavenger receptors	MRC1 CD209	2.52e-03	27	50	2	1253
Coexpression	XU_CREBBP_TARGETS_DN	IGHV3-53 IGHV3-48 IGHV3-21 IGHV3-66	1.30e-05	56	67	4	MM642
ToppCell	10x5'-Liver-Myeloid_Mac-Intestinal_macrophages\|Liver / Manually curated celltypes from each tissue	MRC1 RGL1 ABCA1 MRC2 CD209 ADGRG6	1.32e-07	156	67	6	9a897fc79c4fae94c5f2e9012d65297f9225e5e3
ToppCell	10x5'-lymph-node_spleen-Myeloid_Mac-Intestinal_macrophages\|lymph-node_spleen / Manually curated celltypes from each tissue	MRC1 RGL1 ABCA1 NAIP CD209 ADGRG6	3.07e-07	180	67	6	7be7d7a6906fff6dbdecd9cb013d855aba4eda2a
ToppCell	Children_(3_yrs)-Immune-interstitial_macrophage_(C1Q_positive)-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	MRC1 RGL1 ABCA1 CALCR NAIP CD209	3.61e-07	185	67	6	8207f9eff113eed429e961748c6b17d672a13b33
ToppCell	droplet-Limb_Muscle-MUSCLE-30m-Macroglial-nan\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLC6A1 ENDOD1 PIWIL1 CSMD3 ADGRL3 ADGRG6	3.85e-07	187	67	6	16e55d802fc4e71878305e61ad03806aabd59537
ToppCell	Children_(3_yrs)-Immune-interstitial_macrophage_(C1Q_positive)\|Children_(3_yrs) / Lineage, Cell type, age group and donor	MRC1 RGL1 ABCA1 CALCR NAIP CD209	4.22e-07	190	67	6	f573fef3762a30c38cf8fa7f45df0ffbb49dc873
ToppCell	Tracheal-10x5prime-Immune_Lymphocytic-B\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	TLR10 IGHV3-53 IGHV3-48 IGHV3-21 IL2RG IGHV3-66	5.22e-07	197	67	6	2662138671262b30508c5759038bcdcfe6551696
ToppCell	wk_15-18-Hematologic-Myeloid-SPP1+_Mac\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	MRC1 RGL1 ABCA1 NAIP PLCB2 CD209	5.54e-07	199	67	6	c7fc2ac1601346aac71e7620a8a440fde8d92dbd
ToppCell	Parenchymal-NucSeq-Immune_Myeloid-Macrophage_other-Macrophage_intravascular\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	MRC1 RGL1 CALCR NAIP PLCB2 CD209	5.70e-07	200	67	6	179afc4bee7a2fd85a3b5dadf32544a63807c164
ToppCell	3'_v3-Lung-Myeloid_Mac-Intestinal_macrophages\|Lung / Manually curated celltypes from each tissue	RGL1 CALCR NAIP CD209 ADGRG6	5.64e-06	169	67	5	241644823e6f949aaf4c671d4579721d7ef6b0e5
ToppCell	tumor_Lymph_Node_/_Brain-T/NK_cells-CD8+/CD4+_Mixed_Th\|T/NK_cells / Location, Cell class and cell subclass	MRC1 ANKRD42 NAIP ADGRV1 NEB	6.32e-06	173	67	5	42c911ed16fabdabef063830e8407192d8bde950
ToppCell	5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	TLR10 IGHV3-53 IGHV3-48 IGHV3-21 IGHV3-66	7.25e-06	178	67	5	107dae8b00c4257697a63700e72bb434cdb8406f
ToppCell	5'-Adult-Appendix-Hematopoietic-Myeloid-Macrophages\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MRC1 RGL1 ABCA1 NAIP CD209	8.08e-06	182	67	5	ea39b1b5db185b0cb11dfa2e01f3f972effbd770
ToppCell	Mild_COVID-19-B_cell\|Mild_COVID-19 / Disease group,lineage and cell class （2021.01.30）	TLR10 IGHV3-53 IGHV3-48 IGHV3-21 IGHV3-66	8.30e-06	183	67	5	dea119e2988e954475f557f0bbe12556a83e81a4
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ASXL3 ADGRV1 NEB CSMD3 ADGRL3	8.52e-06	184	67	5	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ASXL3 ADGRV1 NEB CSMD3 ADGRL3	8.52e-06	184	67	5	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ASXL3 ADGRV1 NEB CSMD3 ADGRL3	8.52e-06	184	67	5	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	BAL-Mild-Lymphocyte-B-B_cell-B_cell\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	TLR10 IGHV3-53 IGHV3-48 IGHV3-21 IGHV3-66	8.52e-06	184	67	5	3f8a359e40bebe58545f708682e5e5d1b70cf5cb
ToppCell	BAL-Mild-Lymphocyte-B-B_cell-B_cell-\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	TLR10 IGHV3-53 IGHV3-48 IGHV3-21 IGHV3-66	8.52e-06	184	67	5	64bede8db709fd32f40c03265b96f0b12155bb8a
ToppCell	BAL-Mild-Lymphocyte-B-B_cell\|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)	TLR10 IGHV3-53 IGHV3-48 IGHV3-21 IGHV3-66	8.75e-06	185	67	5	609080adb2cfb105bb7b8efb617553833299f371
ToppCell	Mild_COVID-19-B_cell-B_cell\|Mild_COVID-19 / Disease group,lineage and cell class （2021.01.30）	TLR10 IGHV3-53 IGHV3-48 IGHV3-21 IGHV3-66	8.98e-06	186	67	5	855a5a00ba2aa1b5c63b8db56d026ddecc546050
ToppCell	Monocytes-M2-like_CD16+_macrophages\|Monocytes / Immune cells in Kidney/Urine in Lupus Nephritis	MRC1 ABCA1 NEB CD209 ADGRG6	9.21e-06	187	67	5	59e31c51183ed4c9a3d0792c8005ea3a12b28dfa
ToppCell	PND10\|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MYCBP2 WNT11 SMARCA2 SMARCA4 ADGRL3	9.95e-06	190	67	5	d67e2814047c8df2ae4b7bc8be9539f5df6ecef2
ToppCell	368C-Myeloid-Macrophage-M2-like_Macrophage_(MARCO_negative)\|368C / Donor, Lineage, Cell class and subclass (all cells)	MRC1 RGL1 CALCR NAIP CD209	9.95e-06	190	67	5	cbba3d94a4c3e0b0d14f3b7c60dba5d6e097c5e3
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Immune-Myeloid-Macrophage_Dendritic\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	MRC1 RGL1 PSMA1 PLCB2 ADGRG6	1.05e-05	192	67	5	86d792682ba51696f503c79625dd20f87bcf651f
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	MRC1 RGL1 PSMA1 PLCB2 ADGRG6	1.05e-05	192	67	5	d0ad6a205ad50a3c523fa68676996b289eabc5de
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Immune-Myeloid\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	MRC1 RGL1 PSMA1 PLCB2 ADGRG6	1.07e-05	193	67	5	f597fefc54327a1ad136e2f66b6e81cc5c761eb7
ToppCell	5'-Adult-SmallIntestine-Hematopoietic-Myeloid-Macrophages\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MRC1 RGL1 ABCA1 NAIP CD209	1.10e-05	194	67	5	7c7091de47359760003e910cfbe63db5c99410d6
ToppCell	3'-Child09-12-SmallIntestine-Hematopoietic-Myeloid-LYVE1+_Macrophage\|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MRC1 RGL1 ABCA1 NAIP CD209	1.10e-05	194	67	5	8e2819a9d0529f7b2de1a7c1190575175d6173ee
ToppCell	3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-lung_macrophage\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MRC1 RGL1 ABCA1 NAIP CD209	1.10e-05	194	67	5	48c37251518f96524807b5bd1bbc2820637666ad
ToppCell	3'-Child04-06-SmallIntestine-Hematopoietic-Myeloid-LYVE1+_Macrophage\|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MRC1 RGL1 ABCA1 NAIP CD209	1.10e-05	194	67	5	ad72be9f6871b334e1f477d868c15e7792fadea5
ToppCell	3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-lung_macrophage-Interstitial_macrophage_perivascular-Interstitial_macrophage_perivascular_L.1.2.1.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MRC1 RGL1 ABCA1 NAIP CD209	1.10e-05	194	67	5	7b6a34d1f8922b71dcc931421666c1822cec8345
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	MRC1 RGL1 ABCA1 NAIP CD209	1.10e-05	194	67	5	1dce6d4b6ac41f80677e3e4c335a4f383bd76f85
ToppCell	3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-lung_macrophage-Interstitial_macrophage_perivascular\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MRC1 RGL1 ABCA1 NAIP CD209	1.10e-05	194	67	5	435406ebe626c702f7d5a99a3d68ee85aa09be95
ToppCell	368C-Myeloid-Macrophage-M2-like_Macrophage_(MARCO_negative)\|Macrophage / Donor, Lineage, Cell class and subclass (all cells)	MRC1 RGL1 NAIP CD209 ADGRG6	1.10e-05	194	67	5	58046894446cb250814252a23f60fdd59c114d77
ToppCell	5'-Adult-SmallIntestine-Hematopoietic-Myeloid\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MRC1 RGL1 ABCA1 NAIP CD209	1.13e-05	195	67	5	f289a44010788853d7726d4b5aa75f3c62186c08
ToppCell	3'-Pediatric_IBD-SmallIntestine-Hematopoietic-Myeloid-LYVE1+_Macrophage\|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MRC1 RGL1 ABCA1 NAIP CD209	1.13e-05	195	67	5	c16479a10f5ca2e89aea1742dbc5cc4dc9f3ea88
ToppCell	(3)_MNP-(3)_Macrophage_MARCOneg\|(3)_MNP / Lung cell shreds - cell class (v4) and cell subclass (v4)	MRC1 RGL1 NAIP CD209 ADGRG6	1.13e-05	195	67	5	e4b5e4b8832669fb4d1661ecd828b81e621d35c4
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ABCA1 MYCBP2 CADPS VPS13C SPHKAP	1.13e-05	195	67	5	3e519cffa6144a62b06124642a14c9ff39b76554
ToppCell	3'-GW_trimst-2-SmallIntestine-Hematopoietic-Myeloid-LYVE1+_Macrophage\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MRC1 RGL1 ABCA1 NAIP CD209	1.13e-05	195	67	5	028622b234551b185977fbee10c06851a45456a5
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ABCA1 MYCBP2 CADPS VPS13C SPHKAP	1.13e-05	195	67	5	7796ea9247f4c63762f0de8490fed08b9717fa23
ToppCell	10x5'-GI_small-bowel-Myeloid_Mac-Intestinal_macrophages\|GI_small-bowel / Manually curated celltypes from each tissue	MRC1 RGL1 MRC2 NAIP CD209	1.16e-05	196	67	5	075e5746fa5cb121115a1d51b823c0fbf8d54305
ToppCell	normal_Lung-Myeloid_cells-mo-Mac\|normal_Lung / Location, Cell class and cell subclass	MRC1 RGL1 ABCA1 NAIP CD209	1.16e-05	196	67	5	4d3a3264b3d781139899448cde3b7a4f214ca14d
ToppCell	Smart-seq2-thymus_(Smart-seq2)-myeloid-myeloid_macrophage\|thymus_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	MRC1 RGL1 ABCA1 CD209 ADGRG6	1.19e-05	197	67	5	e3349a381723393cd255f202afedd0c99037939b
ToppCell	Tracheal-10x5prime-Immune_Lymphocytic-B-B_cell-B_naive\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	TLR10 IGHV3-48 IGHV3-21 IL2RG IGHV3-66	1.19e-05	197	67	5	fd65020089baca78334cecddc96b7a65028c2b7c
ToppCell	5'-Adult-LargeIntestine-Hematopoietic-Myeloid-Macrophages\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MRC1 RGL1 ABCA1 NAIP CD209	1.19e-05	197	67	5	e698a0bbb20bd4868ff4348f2ac9f609942b55fa
ToppCell	Tracheal-10x5prime-Immune_Lymphocytic-B-B_cell\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	TLR10 IGHV3-48 IGHV3-21 IL2RG IGHV3-66	1.19e-05	197	67	5	0e56255862fed099e771ebd2529393dc5a3641ba
ToppCell	Smart-seq2-thymus_(Smart-seq2)-myeloid-myeloid_macrophage-macrophage\|thymus_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	MRC1 RGL1 ABCA1 CD209 ADGRG6	1.19e-05	197	67	5	e567886d69c6ea8dec87019c2ebc593793cb3107
ToppCell	distal-Hematologic-IGSF21+_Dendritic\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	MRC1 RGL1 CALCR NAIP CD209	1.19e-05	197	67	5	a357ee2ba9100dfaeba9ecae8138a2776bb54b0b
ToppCell	distal-Hematologic-IGSF21+_Dendritic-3\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	MRC1 RGL1 CALCR NAIP CD209	1.19e-05	197	67	5	e77c91f5a1f5a292eda41abf3b1e31180f2c61e1
ToppCell	Parenchymal-10x5prime-Immune_Lymphocytic-B\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	TLR10 IGHV3-53 IGHV3-48 IGHV3-21 IGHV3-66	1.19e-05	197	67	5	9fe1b757f76c2d43d39aa9ac500eaba98723985c
ToppCell	distal-3-Hematologic-IGSF21+_Dendritic\|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	MRC1 RGL1 CALCR NAIP CD209	1.19e-05	197	67	5	52e9dc35dd8cc2605fa4894bb16bb5c6086faa76
ToppCell	5'-GW_trimst-2-SmallIntestine-Hematopoietic-Myeloid-LYVE1+_Macrophage\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MRC1 RGL1 ABCA1 NAIP CD209	1.21e-05	198	67	5	acb84681569651447d684aa3960f0510d7ff17e8
ToppCell	3'-Child09-12-SmallIntestine-Hematopoietic-Myeloid\|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MRC1 RGL1 ABCA1 NAIP CD209	1.21e-05	198	67	5	af682919a874d60f579e854c274dc47063015ea9
ToppCell	Bronchial-NucSeq-Immune_Myeloid-Macrophage_other-Macrophage_intravascular\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	MRC1 RGL1 ABCA1 NAIP CD209	1.21e-05	198	67	5	c7dbf24caae5c4ef285845d13055de9e07281bb3
ToppCell	wk_20-22-Hematologic-Myeloid-SPP1+_Mac\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	MRC1 RGL1 ABCA1 NAIP CD209	1.24e-05	199	67	5	7c19f1b1f4369edd035ca9cdcf4e653771fc4648
ToppCell	5'-GW_trimst-2-LargeIntestine-Hematopoietic-Myeloid\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MRC1 ABCA1 NAIP PLCB2 CD209	1.24e-05	199	67	5	f34c15df58fbdc6c90e30800e26fabbf828ad10b
ToppCell	cellseq2-Immune-Immune_Myeloid-IM-IM\|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	MRC1 RGL1 ABCA1 NAIP CD209	1.24e-05	199	67	5	372fb9eb90022dc4ac770a75b4e207c33d1d0c43
ToppCell	5'-GW_trimst-2-LargeIntestine-Hematopoietic\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MRC1 ABCA1 NAIP PLCB2 CD209	1.24e-05	199	67	5	5ceeed92f831d068ff4bb3994f420002338330e7
ToppCell	5'-Adult-LargeIntestine-Hematopoietic-Myeloid\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MRC1 RGL1 ABCA1 NAIP CD209	1.24e-05	199	67	5	a4785c1921a3de18a9190e4d674ede6a90f80004
ToppCell	cellseq2-Immune-Immune_Myeloid-IM\|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	MRC1 RGL1 ABCA1 NAIP CD209	1.24e-05	199	67	5	dd3bf59cdc18091889cbf6c43f37100ba537843d
ToppCell	cellseq-Immune-Immune_Myeloid-IM\|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	MRC1 RGL1 ABCA1 NAIP CD209	1.24e-05	199	67	5	b3267d5a7ae0461f5e9e6a3ab6783317a8c42506
ToppCell	cellseq-Immune-Immune_Myeloid-IM-IM\|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	MRC1 RGL1 ABCA1 NAIP CD209	1.24e-05	199	67	5	01dacee8bb392639d475be3cb27ba3eeff1e57f1
ToppCell	Sigmoid-Macrophage-Macrophage\|Sigmoid / Region, Cell class and subclass	MRC1 RGL1 ABCA1 NAIP CD209	1.27e-05	200	67	5	9ee3a799de7bade1bfe94b6827461633f02bc1dc
ToppCell	Parenchyma_Control_(B.)-Immune-TX-MoAM-2\|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type	MRC1 RGL1 ABCA1 NAIP CD209	1.27e-05	200	67	5	670ef1e68be0d2c6ea20ab4dea1d051a3cc89799
ToppCell	Sigmoid-Macrophage\|Sigmoid / Region, Cell class and subclass	MRC1 RGL1 ABCA1 NAIP CD209	1.27e-05	200	67	5	b07ac0ff3b8530e99094678fed80f35949cafac8
ToppCell	Sigmoid-(6)_Macrophage-(60)_Macrophage\|Sigmoid / shred on region, Cell_type, and subtype	MRC1 RGL1 ABCA1 NAIP CD209	1.27e-05	200	67	5	ad84a83a5a1893f7b053d39eddeca851463a8ff0
ToppCell	LPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_only / Treatment groups by lineage, cell group, cell type	SEMA3D ABCA1 MYCBP2 MRC2 LPA	1.27e-05	200	67	5	a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2
ToppCell	Sigmoid-(6)_Macrophage\|Sigmoid / shred on region, Cell_type, and subtype	MRC1 RGL1 ABCA1 NAIP CD209	1.27e-05	200	67	5	9e10cca4429de2c4c8c3c6cf2c9e28637a095be9
ToppCell	normal_Lymph_Node-Myeloid_cells-mo-Mac\|Myeloid_cells / Location, Cell class and cell subclass	MRC1 RGL1 ABCA1 CD209	8.34e-05	153	67	4	5424494ea1f09542799045a875cc3eac13de5079
ToppCell	Adult-Epithelial-basal_cell-D122\|Adult / Lineage, Cell type, age group and donor	SULF1 ASXL3 LPA ADGRG6	8.56e-05	154	67	4	38d346402417960044ae999e61f0092b46f2b591
ToppCell	facs-Limb_Muscle-ForelimbandHindlimb-24m-Myeloid-macrophage\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLC6A1 MRC1 PIWIL1 TICAM2	8.77e-05	155	67	4	d2e489a08b4e711bd2ed483dcc4da7dbbaa4feea
ToppCell	facs-Limb_Muscle-ForelimbandHindlimb-24m-Myeloid\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLC6A1 MRC1 PIWIL1 TICAM2	8.77e-05	155	67	4	cb456d6f13bfb5cb400c0840a0ab6ba4616dcf37
ToppCell	facs-Limb_Muscle-ForelimbandHindlimb-24m-Myeloid-nan\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLC6A1 MRC1 PIWIL1 TICAM2	8.77e-05	155	67	4	a547fdcd974b0813ce6c8cccfec9fff74cac2d1a
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_C_(NP)-Glut_NP_L5/6_FEZF2-Exc_L5-6_FEZF2_CABP7\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	TLR10 PCED1B SULF1 ADGRG6	9.68e-05	159	67	4	109458196bb5be550e36b94b896a9c7f11e52667
ToppCell	368C-Lymphocytic-Plasma_cell-\|368C / Donor, Lineage, Cell class and subclass (all cells)	IGHV3-48 IGHV3-21 IL2RG IGHV3-66	1.04e-04	162	67	4	c21a54310b239d999bbc9d8fb5e8fda16e0bc336
ToppCell	368C-Lymphocytic-Plasma_cell\|368C / Donor, Lineage, Cell class and subclass (all cells)	IGHV3-48 IGHV3-21 IL2RG IGHV3-66	1.04e-04	162	67	4	f945688815229c8386cbcbf46deee7df316fa8d3
ToppCell	368C-Myeloid-Macrophage-M2-like_Macrophage_(MARCO_negative)\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	MRC1 RGL1 CD209 ADGRG6	1.07e-04	163	67	4	4b8abbad4df040c895e3afb240759ebbc66b4d0e
ToppCell	metastatic_Lymph_Node-Myeloid_cells-Pleural_Mac\|Myeloid_cells / Location, Cell class and cell subclass	RGL1 SEMA3D CSMD3 ADGRL3	1.09e-04	164	67	4	362c16ed7fb37bf16601fd5e059d3f3e2ed692b4
ToppCell	droplet-Marrow-BM-30m-Lymphocytic-plasma_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MRC1 RGL1 ABCA1 ADGRL3	1.09e-04	164	67	4	758e85e2f5e7236b345e16c78344d5e0bf17d8dc
ToppCell	PBMC-Mild-Myeloid-cDC-cDC-cDC_11\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	TLR10 MRC2 ADGRL3 ADGRG6	1.14e-04	166	67	4	b1bebcbe17386cb102b11d551e62d46156ce0c68
ToppCell	Endothelial-B-Donor_04\|World / lung cells shred on cell class, cell subclass, sample id	ENDOD1 SEMA3D SULF1 NEB	1.17e-04	167	67	4	6a03d16165e0b003092c39972928981abd4a75aa
ToppCell	367C-Lymphocytic-Plasma_cell-\|367C / Donor, Lineage, Cell class and subclass (all cells)	IGHV3-53 IGHV3-48 IGHV3-21 IGHV3-66	1.17e-04	167	67	4	f2185eb72f0137136f6d71af2a70168fded6c940
ToppCell	367C-Lymphocytic-Plasma_cell\|367C / Donor, Lineage, Cell class and subclass (all cells)	IGHV3-53 IGHV3-48 IGHV3-21 IGHV3-66	1.17e-04	167	67	4	5e768cf24699893e05d1bcb1c92dba2336943a64
ToppCell	facs-Thymus-Thymus_Flowthrough-18m-Lymphocytic-DN4_thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PCED1B PDCD1 MYCBP2 IL2RG	1.17e-04	167	67	4	d72b08b3cbc34b30a11dcf512e472b64d1606ec1
ToppCell	PBMC-Mild-Myeloid-cDC-cDC-cDC_11\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	TLR10 MRC2 ADGRL3 ADGRG6	1.17e-04	167	67	4	e44743b20a7435c579d8e999ddc4ca119d6753f2
ToppCell	facs-Thymus-Thymus_Flowthrough-18m-Lymphocytic-DN4_thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PCED1B PDCD1 MYCBP2 IL2RG	1.17e-04	167	67	4	22f7384ff2044898d7b0b01cb9d9a3cbaa93a9a3
ToppCell	3'_v3-bone_marrow-Myeloid_Mac-Intermediate_macrophages\|bone_marrow / Manually curated celltypes from each tissue	MRC1 RGL1 ABCA1 CD209	1.20e-04	168	67	4	8ade4d098aeecda2d80c1cad1cebe9a063eae948
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2-Exc_L6_FEZF2_TBC1D26\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	SEMA3D NPY2R SULF1 SLC9C2	1.22e-04	169	67	4	2abdd8ae9a5d88aac30992142d1b502c959bc015
ToppCell	3'-GW_trimst-2-SmallIntestine-Epithelial-neuro-epithelial-D_cells_(SST+)\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CALCR CADPS NEB PRDM14	1.28e-04	171	67	4	fa5cc720bd0045d0307439be547b41d56def5b43
ToppCell	droplet-Marrow-BM_(NON-STC)-30m-Lymphocytic-plasma_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLC6A1 MRC1 RGL1 ABCA1	1.31e-04	172	67	4	7295bf3ae21a61dd6bcfa0dfb7a37d0f3e8f94ab
ToppCell	LPS-IL1RA-Myeloid-Dendritic_cells-mDC\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	TLR10 MRC1 PDCD1 PLCB2	1.31e-04	172	67	4	cc0e2a45fa74ee19e41612c3615729462474003a
ToppCell	390C-Myeloid-Macrophage-M2-like_Macrophage_(MARCO_negative)\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	MRC1 FAM120C CD209 ADGRG6	1.34e-04	173	67	4	1f725ff16e28636b20ef26f3fa9be8b47c89378d
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_4-Exc_L4-5_RORB_LCN15\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	PCED1B SEMA3D NPY2R SPHKAP	1.37e-04	174	67	4	2947e5906b172d149412fa4e77476fce4ea695d2
ToppCell	3'_v3-bone_marrow-Lymphocytic_B_plasma-Plasma_cells\|bone_marrow / Manually curated celltypes from each tissue	IGHV3-53 IGHV3-48 IGHV3-21 IGHV3-66	1.40e-04	175	67	4	51301f3f44d3e88397f367cedd1e2abaa2be4c6f
ToppCell	metastatic_Brain-B_lymphocytes-MALT_B_cells\|metastatic_Brain / Location, Cell class and cell subclass	IGHV3-53 IGHV3-48 IGHV3-21 IGHV3-66	1.43e-04	176	67	4	50e207403d48ce1b55a78897adb5519a2430a626
ToppCell	-IPF_03\|World / lung cells shred on cell class, cell subclass, sample id	TLR10 IGHV3-53 IGHV3-48 IGHV3-21	1.46e-04	177	67	4	ae2d2e138946535596fa30a55207f261cafda461
ToppCell	Tracheal-10x3prime_v2-Immune_Myeloid-Macrophage_other-Macrophage_intermediate\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	TLR10 CALCR NAIP	1.48e-04	68	67	3	f1cbc6d72489272c1eb6200f64b8b6444719acda
ToppCell	Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-6_LAMP5_CA13_(Lamp5_Lhx6_1)\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	SLC6A1 SULF1 SPHKAP ADGRG6	1.49e-04	178	67	4	f332c7a96844abecf05ca057480fbea9296688a2
ToppCell	3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells-Plasma_cells_L.1.7.0.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	IGHV3-53 IGHV3-21 IL2RG IGHV3-66	1.56e-04	180	67	4	cea079bc02e08c46600eed05ab9924ec90e1e3d3
ToppCell	5'-Adult-Appendix-Hematopoietic-Myeloid-LYVE1+_Macrophage\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MRC1 RGL1 NAIP TICAM2	1.56e-04	180	67	4	66c7b02d85e32ba3e7530d0c4aff17e7525ccdd8
Disease	MENTAL RETARDATION, AUTOSOMAL DOMINANT 12	SMARCA2 SMARCA4	5.06e-05	5	67	2	C3281201
Disease	peripheral arterial disease, traffic air pollution measurement	TLR10 RGL1 ABCA1 ACER1 ADGRG6	8.10e-05	194	67	5	EFO_0004265, EFO_0007908
Disease	saturated fatty acids measurement	ABCA1 LPA SMARCA4	1.48e-04	45	67	3	EFO_0022304
Disease	total lipids in lipoprotein particles measurement	ABCA1 LPA SMARCA4	1.80e-04	48	67	3	EFO_0022309
Disease	opportunistic bacterial infectious disease (implicated_via_orthology)	SMARCA2 SMARCA4	1.81e-04	9	67	2	DOID:0050340 (implicated_via_orthology)
Disease	free cholesterol to total lipids in small HDL percentage	ABCA1 LPA SMARCA4	2.16e-04	51	67	3	EFO_0022285
Disease	total phospholipids in lipoprotein particles measurement	ABCA1 LPA SMARCA4	2.42e-04	53	67	3	EFO_0022315
Disease	peripheral arterial disease	LPA SMARCA4 CSMD3	2.55e-04	54	67	3	EFO_0004265
Disease	tuberculosis (is_marker_for)	PDCD1 CD209	2.76e-04	11	67	2	DOID:399 (is_marker_for)
Disease	cholesterol to total lipids in large LDL percentage	ABCA1 LPA SMARCA4	2.85e-04	56	67	3	EFO_0022235
Disease	low density lipoprotein particle size measurement	ABCA1 LPA SMARCA4	3.16e-04	58	67	3	EFO_0008593
Disease	Coffin-Siris syndrome	SMARCA2 SMARCA4	3.90e-04	13	67	2	C0265338
Disease	Burkitt Leukemia	SALL3 SMARCA4	5.23e-04	15	67	2	C4721444
Disease	African Burkitt's lymphoma	SALL3 SMARCA4	5.23e-04	15	67	2	C0343640
Disease	Epilepsy, Cryptogenic	SLC6A1 NPY2R ASXL3	8.72e-04	82	67	3	C0086237
Disease	Awakening Epilepsy	SLC6A1 NPY2R ASXL3	8.72e-04	82	67	3	C0751111
Disease	Aura	SLC6A1 NPY2R ASXL3	8.72e-04	82	67	3	C0236018
Disease	temporal lobe epilepsy (is_marker_for)	SLC6A1 NPY2R	9.40e-04	20	67	2	DOID:3328 (is_marker_for)
Disease	lipoprotein measurement, phospholipid measurement	ABCA1 LPA SMARCA4	9.67e-04	85	67	3	EFO_0004639, EFO_0004732
Disease	stroke, coronary artery disease	LPA SMARCA4	1.04e-03	21	67	2	EFO_0000712, EFO_0001645
Disease	cholesteryl esters to total lipids in chylomicrons and extremely large VLDL percentage	LPA SMARCA4	1.04e-03	21	67	2	EFO_0022246
Disease	lipid measurement, lipoprotein measurement	ABCA1 LPA SMARCA4	1.14e-03	90	67	3	EFO_0004529, EFO_0004732
Disease	large artery stroke, coronary artery disease	LPA SMARCA4	1.47e-03	25	67	2	EFO_0001645, EFO_0005524
Disease	total cholesterol measurement, intermediate density lipoprotein measurement	ABCA1 LPA SMARCA4	1.50e-03	99	67	3	EFO_0004574, EFO_0008595
Disease	low density lipoprotein cholesterol measurement, alcohol consumption measurement	ABCA1 LPA SMARCA4	1.50e-03	99	67	3	EFO_0004611, EFO_0007878
Disease	colon carcinoma	RGL1 ZCWPW2	1.59e-03	26	67	2	EFO_1001950
Disease	low density lipoprotein cholesterol measurement, alcohol drinking	ABCA1 LPA SMARCA4	1.64e-03	102	67	3	EFO_0004329, EFO_0004611
Disease	Sezary Syndrome	SMARCA4 IL2RG	1.72e-03	27	67	2	C0036920
Disease	free cholesterol measurement, intermediate density lipoprotein measurement	ABCA1 LPA SMARCA4	1.73e-03	104	67	3	EFO_0008591, EFO_0008595
Disease	Epilepsy	SLC6A1 NPY2R ASXL3	1.98e-03	109	67	3	C0014544
Disease	triglyceride measurement, intermediate density lipoprotein measurement	ABCA1 LPA SMARCA4	2.08e-03	111	67	3	EFO_0004530, EFO_0008595
Disease	opioid dependence	SULF1 SMARCA2 ADGRV1 CSMD3	2.09e-03	237	67	4	EFO_0005611
Disease	free cholesterol measurement	ABCA1 LPA SMARCA4	2.19e-03	113	67	3	EFO_0008591
Disease	low density lipoprotein cholesterol measurement, lipid measurement	ABCA1 LPA SMARCA4	2.25e-03	114	67	3	EFO_0004529, EFO_0004611
Disease	conotruncal heart malformations	CALCR ADGRV1 TICAM2	2.25e-03	114	67	3	MONDO_0016581
Disease	total cholesterol measurement, low density lipoprotein cholesterol measurement	ABCA1 LPA SMARCA4	2.25e-03	114	67	3	EFO_0004574, EFO_0004611
Disease	cholesteryl esters to total lipids in large LDL percentage	ABCA1 LPA	2.26e-03	31	67	2	EFO_0022249

Protein segments in the cluster

Peptide	Gene	Start	Entry
YTWAQVDAMFSLNCS	URB2	611	Q14146
NSWVQRELPMASAYC	NAIP	256	Q13075
SYRFRSVWPENTMCA	EPB42	636	P16452
DSYPNLQMCAWSISV	CSMD3	2476	Q7Z407
MPSIFAYQSSEVDWC	ACER1	1	Q8TDN7
HPENNRTWSNYTMCN	CALCR	121	P30988
RTWSNYTMCNAFTPE	CALCR	126	P30988
CYPNDYPNSQACMWT	ADGRG6	56	Q86SQ4
CSHWQLTQMFQRFYP	BCS1L	356	Q9Y276
SNFVWDMCNYVVPAT	ABCA1	1701	O95477
FNPNCSFWSYSKRTM	ADGRL3	801	Q9HAR2
MSALYCWNSERNQFS	ADGRV1	3526	Q8WXG9
AQTWPNMTSQAFEAY	ARGFX	281	A6NJG6
TYFPFDWQNCTMVFS	CHRNB1	156	P11230
NCYFMSNSQRNWHDS	CD209	266	Q9NNX6
YNPSNRICWNDDGMR	ASXL3	1601	Q9C0F0
RPSKNCRASWSMNDY	ANKRD42	371	Q8N9B4
NSYCMTPDQKFIQWF	RGL1	466	Q9NZL6
CSTFANPLLYGWMNS	NPY2R	316	P49146
WLMAQCDTYTPAAFA	LTN1	151	O94822
RLFDQWYNSSMNVIC	CADPS	1256	Q9ULU8
FTVSSNYMSWVRQAP	IGHV3-66	46	A0A0C4DH42
IDQQMTFPVQCSFWS	MCMDC2	446	Q4G0Z9
TNSAPMTQSFQERWY	ENDOD1	161	O94919
FTFSSYEMNWVRQAP	IGHV3-48	46	P01763
ESFVLNWYRMSPSNQ	PDCD1	61	Q15116
RYNMNDAIFSVACAW	JRK	356	O75564
DMWYQTVNTCFLPRA	NXF5	341	Q9H1B4
MNSCLWDISRYGPNS	PCED1B	121	Q96HM7
PSMLSHNSCYWIQSN	MRC2	1361	Q9UBG0
MFRNQYDNDVTVWSP	PSMA1	1	P25786
FTFSSYSMNWVRQAP	IGHV3-21	46	A0A0B4J1V1
MWYSCFVQQPSLQDT	IFT22	101	Q9H7X7
SPADMRLNNSVFQWY	DNAH7	646	Q8WXX0
MLQNSPFANWAVSYD	FAM120C	486	Q9NX05
TMDPSVRWEYCNLTQ	LPA	1116	P08519
TMDPSVRWEYCNLTQ	LPA	1336	P08519
NVEYMNCTWNSSSEP	IL2RG	66	P31785
QCNPDWMIYFRQFSQ	HELQ	881	Q8TDG4
FRIYSKDFWNQCMPD	DHX40	406	Q8IX18
AARAMNVDPSFWNQY	SALL3	1201	Q9BXA9
FTVSSNYMSWVRQAP	IGHV3-53	46	P01767
DENCVTMYSNSGFWN	MRC1	896	P22897
PYSNAFAWLQMETSN	MRC1	1136	P22897
AALRAWNSCNEYMPS	PIWIL1	681	Q96J94
WASMLNNFCSYFNLN	TAS2R16	61	Q9NYV7
PQLDCFLSMTVSWYQ	SZT2	3321	Q5T011
STDYWLQNQRMPCQI	SPHKAP	56	Q2M3C7
NPWNTDRCFSNYSMV	SLC6A1	166	P30531
CSTFEQWFNAPFAMT	SMARCA2	906	P51531
TGNWMSYVNCARFPK	PRDM14	321	Q9GZV8
NCSWPETVVNMNLSY	TLR10	416	Q9BXR5
CSTFEQWFNAPFAMT	SMARCA4	936	P51532
VPNMNGYTEAWCLSF	MYCBP2	2526	O75592
DTWCNFQFYTSLMNS	TICAM2	146	Q86XR7
SSPNFSLDQYCEQMW	SEMA3D	721	O95025
AYMPQSRNLSAFFNW	CHST5	131	Q9GZS9
NMSKFFQYGWRCTTN	C11orf1	46	Q9H5F2
WPRAYNLTNFSSMFT	SETDB2	276	Q96T68
MSQRSFPASFWNSAY	VGLL2	136	Q8N8G2
EKGPCQTYMTRWFFN	SPINT3	41	P49223
SAYWNVNCSMSYQRS	VPS13C	256	Q709C8
YLTWSAMSNEPDRSC	SERINC3	281	Q13530
DSSNYMPQMFWNAGC	PLCB2	611	Q00722
RYNNSTNWNMVTLCF	TMEM222	156	Q9H0R3
DMRWNCSSIELAPNY	WNT11	86	O96014
MSSYFWAQNESNRPD	SLC9C2	1	Q5TAH2
EPWYCFMNTDSRYNN	ZCWPW2	56	Q504Y3
YTNNENCSSPSWQAM	SULF1	106	Q8IWU6
EDSPATFYCISMQWF	USP33	841	Q8TEY7
YRNYLHQWTCMPDQN	NEB	4081	P20929